Treace Medical Concepts TMCI
NASDAQ TMCI
$4.35 -0.21 (-4.61%)
At close: Aug 20, 2026 · 2:33 PM UTC

Treace Medical Concepts (TMCI) Net Cash Flow Growth (3y) (2023 - 2026)

Treace Medical Concepts (TMCI) Net Cash Flow Growth (3y) (2023 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF Growth (3y) (Qtr)
1 Abbott Laboratories 199.46 Bn 193.86 Bn 7.27 Bn -9.45%
2 Stryker 127.41 Bn 123.93 Bn 4.50 Bn 60.16%
3 Medtronic 118.87 Bn 109.65 Bn 6.41 Bn 31.32%
4 Boston Scientific 73.47 Bn 72.93 Bn 3.85 Bn -85.83%
5 Edwards Lifesciences 51.95 Bn 47.69 Bn 1.35 Bn 43.26%
6 Dexcom 34.30 Bn 32.35 Bn 830.00 Mn -26.30%
7 GE HealthCare Technologies 33.76 Bn 31.65 Bn 2.18 Bn 21.48%
8 Koninklijke Philips 26.35 Bn 23.02 Bn 4.55 Bn -127.77%
9 Steris 23.04 Bn 22.55 Bn 684.20 Mn 269.22%
10 Treace Medical Concepts 281.67 Mn 236.05 Mn 35.61 Mn 29.55%

Historic Data

Download Data
DateValue
Jun 30, 2026 29.55%
Mar 31, 2026 -28.36%
Dec 31, 2025 26.90%
Sep 30, 2025 69.57%
Jun 30, 2025 -55.23%
Mar 31, 2025 31.52%
Dec 31, 2024 40.60%
Sep 30, 2024 15.78%
Jun 30, 2024 -55.94%
Mar 31, 2024 -25.15%
Dec 31, 2023 28.68%
Sep 30, 2023 -43.17%
Jun 30, 2023 -289.27%
Mar 31, 2023 104.89%